These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 26381996)

  • 1. Antifungal prophylaxis in pediatric patients undergoing therapy for cancer: drugs and dosing.
    Lehrnbecher T
    Curr Opin Infect Dis; 2015 Dec; 28(6):523-31. PubMed ID: 26381996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and pharmacodynamics of antifungals in children: clinical implications.
    Autmizguine J; Guptill JT; Cohen-Wolkowiez M; Benjamin DK; Capparelli EV
    Drugs; 2014 Jun; 74(8):891-909. PubMed ID: 24872147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preventing invasive fungal disease in patients with haematological malignancies and the recipients of haematopoietic stem cell transplantation: practical aspects.
    Akan H; Antia VP; Kouba M; Sinkó J; Tănase AD; Vrhovac R; Herbrecht R
    J Antimicrob Chemother; 2013 Nov; 68 Suppl 3():iii5-16. PubMed ID: 24155144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Posaconazole prophylaxis--impact on incidence of invasive fungal disease and antifungal treatment in haematological patients.
    Peterson L; Ostermann J; Rieger H; Ostermann H; Rieger CT
    Mycoses; 2013 Nov; 56(6):651-8. PubMed ID: 23710592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current practice of antifungal prophylaxis and treatment in immunocompromised children and adults with malignancies: a single centre approach.
    Lehrnbecher T; Mousset S; Sörensen J; Böhme A
    Mycoses; 2009 Mar; 52(2):107-17. PubMed ID: 18983431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prophylaxis and treatment of invasive fungal diseases in allogeneic stem cell transplantation: results of a consensus process by Gruppo Italiano Trapianto di Midollo Osseo (GITMO).
    Girmenia C; Barosi G; Aversa F; Bacigalupo A; Barbui T; Baronciani D; Bosi A; Candoni A; Locasciulli A; Locatelli F; Menichetti F; Musso M; Viscoli C; Rambaldi A
    Clin Infect Dis; 2009 Oct; 49(8):1226-36. PubMed ID: 19772390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liposomal amphotericin B twice weekly as antifungal prophylaxis in paediatric haematological malignancy patients.
    Bochennek K; Tramsen L; Schedler N; Becker M; Klingebiel T; Groll AH; Lehrnbecher T
    Clin Microbiol Infect; 2011 Dec; 17(12):1868-74. PubMed ID: 21895857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Micafungin twice weekly as antifungal prophylaxis in paediatric patients at high risk for invasive fungal disease.
    Bochennek K; Balan A; Müller-Scholden L; Becker M; Farowski F; Müller C; Groll AH; Lehrnbecher T
    J Antimicrob Chemother; 2015 May; 70(5):1527-30. PubMed ID: 25564562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antifungal prophylaxis in lung transplantation.
    Neoh CF; Snell G; Levvey B; Morrissey CO; Stewart K; Kong DC
    Int J Antimicrob Agents; 2014 Sep; 44(3):194-202. PubMed ID: 25123811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Micafungin: a brief review of pharmacology, safety, and antifungal efficacy in pediatric patients.
    Lehrnbecher T; Groll AH
    Pediatr Blood Cancer; 2010 Aug; 55(2):229-32. PubMed ID: 20583216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pediatric antifungal agents.
    Cohen-Wolkowiez M; Moran C; Benjamin DK; Smith PB
    Curr Opin Infect Dis; 2009 Dec; 22(6):553-8. PubMed ID: 19741525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prevention of fungal infections in children and adolescents with cancer].
    Groll AH; Ritter J; Müller FM
    Klin Padiatr; 2001 Sep; 213 Suppl 1():A50-68. PubMed ID: 11577364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antifungal prophylaxis during treatment for haematological malignancies: are we there yet?
    Rogers TR; Slavin MA; Donnelly JP
    Br J Haematol; 2011 Jun; 153(6):681-97. PubMed ID: 21504422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breakthrough invasive fungal disease in patients receiving posaconazole primary prophylaxis: a 4-year study.
    Lerolle N; Raffoux E; Socie G; Touratier S; Sauvageon H; Porcher R; Bretagne S; Bergeron A; Azoulay E; Molina JM; Lafaurie M
    Clin Microbiol Infect; 2014 Nov; 20(11):O952-9. PubMed ID: 24861577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update on antifungal agents for paediatric patients.
    Groll AH; Tragiannidis A
    Clin Microbiol Infect; 2010 Sep; 16(9):1343-53. PubMed ID: 20678177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prophylaxis, pre-emptive or empirical antifungal therapy: which is best in non-lung transplant recipients?
    Salavert M
    Int J Antimicrob Agents; 2008 Nov; 32 Suppl 2():S149-53. PubMed ID: 19013340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antifungal prophylaxis associated with decreased induction mortality rates and resources utilized in children with new-onset acute myeloid leukemia.
    Fisher BT; Kavcic M; Li Y; Seif AE; Bagatell R; Huang YS; Zaoutis T; Torp K; Leckerman KH; Aplenc R
    Clin Infect Dis; 2014 Feb; 58(4):502-8. PubMed ID: 24270167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indications and outcomes of antifungal therapy in French patients with haematological conditions or recipients of haematopoietic stem cell transplantation.
    Herbrecht R; Caillot D; Cordonnier C; Auvrignon A; Thiébaut A; Brethon B; Michallet M; Mahlaoui N; Bertrand Y; Preziosi P; Ruiz F; Gorin NC; Gangneux JP
    J Antimicrob Chemother; 2012 Nov; 67(11):2731-8. PubMed ID: 22850692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pre-emptive diagnosis and treatment of fungal infections--evaluation of a single-centre policy.
    Schneider T; Halter J; Heim D; Passweg J; Stern M; Tichelli A; Weisser M; Gerull S
    Clin Microbiol Infect; 2012 Feb; 18(2):189-94. PubMed ID: 21729194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antifungal prophylaxis with posaconazole vs. fluconazole or itraconazole in pediatric patients with neutropenia.
    Döring M; Eikemeier M; Cabanillas Stanchi KM; Hartmann U; Ebinger M; Schwarze CP; Schulz A; Handgretinger R; Müller I
    Eur J Clin Microbiol Infect Dis; 2015 Jun; 34(6):1189-200. PubMed ID: 25680318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.